Search

everythinglearnresearchcommunity

for

Search:↓

The 2017 issue emphasized progress in laser and energy-based skin treatments, but noted the need for more research on certain procedures and technologies.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Oral methylprednisolone pulse therapy helped an 11-year-old regrow 80% of his hair in six months.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Dr. Dominic A. Brandy shared methods to fix aesthetic problems from old hair restoration techniques, using methods like follicular unit grafting and scalp removal, which helped patients look more natural after surgery. He also suggested using oral finasteride and topical minoxidil to control hair loss in most men with baldness, especially those who had flap surgery.

Using your own blood (PRP) can effectively increase hair count and strength in men with hair loss.

Artificial hair fibers help treat scalp scars with few complications and a 20% yearly fiber fall rate.

Targeting colon cancer stem cells might lead to better treatment results.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Zinc is effective for treating various skin conditions, including warts and acne.

Hair loss causes stress and affects mental health; treatment and support needed.

Latanoprost can make eyelashes longer, thicker, and darker.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Microneedles help improve skin appearance and deliver skin treatments effectively, but safety concerns need more research and regulation.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.